Sphingosine 1-phosphate receptor 1 — Drug Target

All drugs that target Sphingosine 1-phosphate receptor 1 — marketed and clinical-stage. Includes 2 drug classes acting on this target.

Drug classes

Sphingosine 1-phosphate Receptor Modulator [EPC] · Sphingosine 1-phosphate Receptor Modulator

Marketed (3)

• Mayzent · Novartis · Sphingosine 1-phosphate Receptor Modulator [EPC] · Neuroscience
  Mayzent works by binding to the sphingosine 1-phosphate receptor 1, which helps to reduce inflammation and slow disease progression.
• Zeposia · Bristol-Myers Squibb · Sphingosine 1-phosphate Receptor Modulator · Immunology
  Zeposia works by binding to the sphingosine 1-phosphate receptor 1, which helps to reduce inflammation and slow disease progression.
• Gilenya · Novartis · Sphingosine 1-phosphate Receptor Modulator · Immunology
  Gilenya works by binding to and blocking the S1P1 receptor, preventing immune cells from leaving the lymph nodes and reducing inflammation in the central nervous system.